SCHEMBL7598798

SCHEMBL7598798

N=C(Nc1cccc(CN2CCCC(O)C2)c1)c1cccs1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.51
ACKR3 P25106 9/20 0.51
HTT P42858 1/20 0.47
TSHR P16473 1/20 0.43
KDM4E B2RXH2 2/20 0.41
POLB P06746 1/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PDCD1 Q15116 1/20 0.40
CD274 Q9NZQ7 1/20 0.40
MEN1 O00255 1/20 0.40
MAPT P10636 1/20 0.40
KMT2A Q03164 1/20 0.40
CHRM2 P08172 1/20 0.40
CHRM3 P20309 1/20 0.40
CNR2 P34972 1/20 0.39
BCHE P06276 1/20 0.39
MAOB P27338 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7601787 0.99 ACKR3 (0.50) ALDH1A1ACKR3HTTTSHRKDM4E
SCHEMBL7599399 0.87 ACKR3 (0.59) ALDH1A1ACKR3KDM4ESMN1; SMN2CHRM2
Hydrochloric Acid SCHEMBL7602388 0.86 ACKR3 (0.58) ALDH1A1ACKR3KDM4ESMN1; SMN2CHRM2
SCHEMBL5380801 0.81 ACKR3 (0.54) ACKR3HTTKDM4ESMN1; SMN2CHRM3
SCHEMBL7598672 0.79 ACKR3 (0.46) ALDH1A1ACKR3
SCHEMBL7600199 0.79 ACKR3 (0.46) ALDH1A1ACKR3
Hydrochloric Acid SCHEMBL7598156 0.78 ACKR3 (0.46) ALDH1A1ACKR3
Hydrochloric Acid SCHEMBL7602738 0.78 ACKR3 (0.46) ALDH1A1ACKR3
SCHEMBL6968869 0.78 DRD2 (0.47) ALDH1A1ACKR3KDM4EPOLBMEN1
SCHEMBL6957602 0.77 ACKR3 (0.48) ALDH1A1ACKR3HTTKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020137750-A1 Amidine derivatives which are inhibitors of nitric oxide synthase ASTRAZENECA AB (SE) 2002-09-26 US claimed
WO-2001046171-A1 AMIDINE DERIVATIVES WHICH ARE INHIBITORS OF NITRIC OXIDE SYNTHASE ASTRAZENECA AB (SE) 2001-06-28 WO claimed
US-20020137750-A1 Amidine derivatives which are inhibitors of nitric oxide synthase ASTRAZENECA AB (SE) 2002-09-26 US disclosed
WO-2001046171-A1 AMIDINE DERIVATIVES WHICH ARE INHIBITORS OF NITRIC OXIDE SYNTHASE ASTRAZENECA AB (SE) 2001-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020137750-A1 Amidine derivatives which are inhibitors of nitric oxide synthase NOS1, NOS2, NOS3 ALDH1A1 449/4885ACKR3 3704/4885HTT 4725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.